Literature DB >> 3658975

Pathogenic factors in the later pulmonary phase of Angiostrongylus cantonensis-infected rats.

A I Ishii1.   

Abstract

In rats infected with different worm burdens of Angiostrongylus cantonensis, the loss of body weight was proportional to the increasing dose of infection. Body weight was correlated inversely with female worm burden (r = -0.669), the sum of mean numbers of larvae per gram of faeces (LPG) (r = -0.527) and lung weight (r = -0.761). Lung weight was positively correlated with female worm burden (r = 0.785) and the sum of mean numbers of LPG (r = 0.685). On the other hand, in rats infected with larvae developed from gamma-irradiated first-stage larvae (Experiment B) or infected rats treated with the drug ivermectin (Experiment C), body weight was inversely correlated with the sum of mean numbers of LPG (r = -0.798, Experiment B; r = -0.670, Experiment C) and lung weight (r = -0.862, Experiment B; r = -0.812, Experiment C), but not with female worm burden. Furthermore, lung weight was positively correlated with the sum of mean numbers of LPG (r = -0.783, Experiment B; r = 0.899, Experiment C), but not with the female worm burden. From these results, it is concluded that in the later pulmonary phase of infection in rats the pathogenic effects may be closely related to the increasing number of first-stage larvae produced by female worms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3658975     DOI: 10.1007/bf00538205

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  14 in total

Review 1.  Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response.

Authors:  O D Ratnoff
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

2.  Effect of 1-tetramisole on Angiostrongylus cantonensis infection in rats.

Authors:  K Jindrak; J E Alicata
Journal:  Chemotherapy       Date:  1969       Impact factor: 2.544

3.  Early migration and pathogenicity of Angiostrongylus cantonensis in laboratory rats.

Authors:  K Jindrák
Journal:  Ann Trop Med Parasitol       Date:  1968-12

4.  Therapeutic effect of thiabendazole on Angiostrongylus cantonensis infections in rats.

Authors:  A C Cuckler; J R Egerton; J E Alicata
Journal:  J Parasitol       Date:  1965-06       Impact factor: 1.276

5.  Late development and fertility of adult worms derived from gamma-irradiated first-stage larvae of Angiostrongylus cantonensis.

Authors:  A I Ishii; M Honda; M Sano
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

6.  Parasite density and the fecundity of Angiostrongylus cantonensis in rats.

Authors:  H Kino
Journal:  Parasitology       Date:  1984-10       Impact factor: 3.234

7.  Studies on chemotherapy of parasitic helminths: effects of avermectin B1a on Angiostrongylus cantonensis in rats.

Authors:  A I Ishii; M Terada; H Kino; M Hayashi; M Sano
Journal:  Int J Parasitol       Date:  1983-10       Impact factor: 3.981

8.  Population dynamics of Angiostrongylus cantonensis during primary infections in rats.

Authors:  Y W Kwong; C Dobson
Journal:  Parasitology       Date:  1982-10       Impact factor: 3.234

9.  A comparison of the effects of flubendazole and thiabendazole on the larvae of Angiostrongylus cantonensis, Trichinella spiralis, Diphyllobothrium erinacei and Hymenolepis nana in mice.

Authors:  J Maki; T Yanagisawa
Journal:  Parasitology       Date:  1983-12       Impact factor: 3.234

View more
  2 in total

1.  [Effect of the anthelminthic levamisole on the first-stage larva of Angiostrongylus cantonensis in infected rats].

Authors:  A Ishih
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

2.  Angiostrongylus cantonensis: tegumental and hypodermic alterations of the fourth-stage larvae following administration of tribendimidine in vivo and in vitro.

Authors:  Xin Zeng; Juan Wang; Jie Wei; Feng Wu; Feng Fung; Xiaoying Wu; Xi Sun; Huanqing Zheng; Zhiyue Lv; Zhongdao Wu
Journal:  Parasitol Res       Date:  2013-06-02       Impact factor: 2.289

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.